NBSE Stock Ownership Activity
NEUBASE THERAPEUTICS INC 13F holders
No value investing guru has made any change to the NEUBASE THERAPEUTICS INC (NBSE) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying NBSE now?
According to the latest SEC filing(s) NEUBASE THERAPEUTICS INC (NBSE) has not been purchased by any super investor.
To see more about who is investing in NEUBASE THERAPEUTICS INC (NBSE), please go to the NBSE ownership page.
2024 Q2
(1 result)
Current price: $0.38
15.54%
Reported price*: $0.45
2023 Q2
(1 result)
Current price: $0.38
79.68%
Reported price*: $1.87
2 of 2
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.